Όλο το DSpace

Πλοήγηση ανά Θέμα "chill"

Αποτελέσματα 1-7 από 7

    • Clinical and laboratory characteristics, epidemiology, and outcomes of murine typhus: A systematic review 

      Tsioutis C., Zafeiri M., Avramopoulos A., Prousali E., Miligkos M., Karageorgos S.A. (2017)
      Murine or endemic typhus, a febrile disease caused by Rickettsia typhi, is often misdiagnosed due to its non-specific presentation. We sought to evaluate all available evidence in the literature regarding the clinical and ...

    • Epidermal growth factor in the treatment of diabetic foot ulcers: An update 

      Tiaka, E. K.; Papanas, N.; Manolakis, A. C.; Georgiadis, G. S. (2012)
      Management of diabetic foot ulcers remains a rather challenging task. Epidermal growth factor (EGF) plays a central role in wound healing. It acts on epithelial cells and fibroblasts promoting restoration of damaged ...

    • Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: Real-world evidence from Greek healthcare workers 

      Kontopoulou K., Ainatzoglou A., Ifantidou A., Nakas C.T., Gkounti G., Adamopoulos V., Papadopoulos N., Papazisis G. (2021)
      Real-world data regarding the effectiveness, safety and immunogenicity of the Pfizer-BioNTech BNT162b2 mRNA vaccine are accumulating in the literature, suggesting that this vaccine generates high titres of S1-binding IgG ...

    • Immunotherapy of systemic sclerosis 

      Katsiari C.G., Simopoulou T., Alexiou I., Sakkas L.I. (2018)
      Systemic sclerosis (SSc) is a chronic systemic disease characterized by microvasculopathy, immune activation, and extensive collagen deposition. Microvasculopathy and immune activation occur very early in the disease ...

    • Imported Chikungunya fever case in Greece in June 2014 and public health response 

      Tsiodras S., Pervanidou D., Papadopoulou E., Kavatha D., Baka A., Koliopoulos G., Badieritakis E., Michaelakis A., Gavana E., Patsoula E., Tsimpos I., Gioksari T., Kyriazopoulou E., Vakali A., Pavli A., Maltezou H.C., Georgakopoulou T., Hadjichristodoulou C., Kremastinou J., Papa A. (2016)
      We report about the first imported case of Chikungunya fever in Greece in a Greek traveler returning from the Dominican Republic and the associated public health response. We investigated the case and performed focused ...

    • Infliximab therapy for patients with active and refractory spondyloarthropathies at the dose of 3 mg/kg: A 20-month open treatment 

      Cherouvim, E. P.; Zintzaras, E.; Boki, K. A.; Moutsopoulos, H. M.; Manoussakis, M. N. (2004)
      Background: Infliximab at the dose of 5 mg/kg per infusion has been shown effective for the treatment of active spondyloarthropathies. It is not clear if the 5 mg/kg is required in most patients. Objective: To evaluate the ...

    • Tuberculous pyomyositis: A re-emerging entity of many faces 

      Simopoulou T., Varna A., Dailiana Z., Katsiari C., Alexiou I., Basdekis G., Malizos K.N., Sakkas L.I. (2016)
      Tuberculosis (TB) has become a global concern due to its increasing incidence, particularly in immunocompromised patients, closely following the migratory patterns of populations. TB pyomyositis is a rare extrapulmonary ...